Back to all papers

Artificial Intelligence in Pulmonary Hypertension: Advancements, Opportunities, and Challenges.

November 7, 2026pubmed logopapers

Authors

Li X,Zhang L,Zhang L,Xie Y,Xie M,Ji M,He Q,Wu Z,Qin S,Li Y

Affiliations (4)

  • Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan 430022, China.
  • Clinical Research Center for Medical Imaging in Hubei Province, Wuhan 430022, China.
  • Hubei Province Key Laboratory of Molecular Imaging, Wuhan 430022, China.
  • Key Laboratory of Biological Targeted Therapy, Huazhong University of Science and Technology, Ministry of Education, Wuhan 430022, China.

Abstract

Pulmonary hypertension (PH) is a progressive cardiopulmonary disorder associated with high morbidity and mortality. Delayed diagnosis, heterogeneous disease phenotypes, and variable treatment responses remain major clinical challenges. Artificial intelligence (AI), including machine learning and deep learning, has emerged as a promising tool for improving PH management. AI-based models have demonstrated promising performance in screening, diagnosis, classification, risk stratification, and prognosis prediction using multimodal data such as electrocardiography, chest radiography, computed tomography, cardiac magnetic resonance imaging, echocardiography, and electronic health records. Furthermore, AI may support individualized risk assessment, treatment-response prediction, early identification of right ventricular deterioration, and longitudinal remote monitoring. Emerging technologies, including explainable AI, federated learning, large language models, and digital twins, may further advance precision medicine in PH. Despite these advances, data quality, interpretability, privacy, and clinical implementation of AI remain challenges. This review summarizes current applications, opportunities, and challenges of AI in PH and discusses future directions for AI-assisted precision healthcare.

Topics

Journal ArticleReview

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.